川宁生物

- 301301

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018 
川宁生物(301301) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入152,321.82482,333.50358,133.34241,719.92126,973.33
营业收入152,321.82482,333.50358,133.34241,719.92126,973.33
二、营业总成本109,863.98364,883.00276,837.23190,301.86104,086.14
营业成本99,893.50330,039.71250,931.85173,083.2193,760.88
营业税金及附加1,971.816,664.605,414.423,728.181,968.95
销售费用384.742,256.651,462.89884.29474.70
管理费用4,679.0114,313.1510,707.387,343.654,106.20
财务费用1,266.716,083.104,414.972,905.362,397.92
研发费用1,668.225,525.813,905.722,357.171,377.48
资产减值损失----------
公允价值变动收益-51.99-118.40-181.84-539.48-223.67
投资收益-306.55-1,355.07-1,158.12-745.96-72.06
其中:对联营企业和合营企业的投资收益-3.89-14.55-10.58-6.24-2.71
汇兑收益----------
三、营业利润42,322.75112,139.9777,673.7747,535.7121,323.74
加:营业外收入4.54197.9919.0817.453.35
减:营业外支出135.33566.85833.90577.12288.59
其中:非流动资产处置损失----------
四、利润总额42,191.96111,771.1176,858.9546,976.0421,038.51
减:所得税费用6,929.3517,714.6112,843.997,889.183,493.84
五、净利润35,262.6194,056.5064,014.9639,086.8717,544.67
归属于母公司所有者的净利润35,261.4994,056.4064,014.9839,086.8717,544.67
少数股东损益1.120.10-0.02-0.00-0.00
六、每股收益
基本每股收益(元/股)0.16000.42000.29000.18000.0800
稀释每股收益(元/股)0.16000.42000.29000.18000.0800
七、其他综合收益----------
八、综合收益总额35,262.6194,056.5064,014.9639,086.8717,544.67
归属于母公司所有者的综合收益总额35,261.4994,056.4064,014.9839,086.8717,544.67
归属于少数股东的综合收益总额1.120.10-0.02-0.00-0.00
下载全部历史数据到excel中 返回页顶